Affiliation:
1. Niigata University Faculty of Medicine
Abstract
Abstract
Background: Although the impact of a history of coronary artery disease (CAD), cerebrovascular disease (CVD) or both and diabetes mellites (DM) on cardiovascular disease is essential for cardiovascular risk management in clinical practice, little is known about such an impact. Therefore, we investigated the association of prior CAD, prior CVD, DM and their combinations with the risk of subsequent cardiovascular disease.
Methods: This historical cohort study included 342,033 participants aged 18-72 years followed for ≥5 years between 2008-2016. Eight groups were created according to whether they were with or without prior CAD, prior CVD and/or DM. DM was defined by fasting plasma glucose, HbA1c and antidiabetic drug prescription. Prior and subsequent CAD and CVD were identified by claims using ICD-10 codes, medical procedures and questionnaires. Cox regression models evaluated the risk of cardiovascular events.
Results: Median follow-up period was 6.4 years. Incidence of composite cardiovascular events due to CAD and/or CVD in CAD-/CVD-, CAD+/CVD-, CAD-/CVD+ and CAD+/CVD+ groups were 1.92, 6.94, 25.14 and 31.98 per 1,000 person-years in non-DM and 8.66, 18.04, 39.98 and 60.72 in DM, respectively. Hazard ratio of cardiovascular events compared to CAD-/CVD-/non-DM were 1.66 (95% CI 1.55-1.78) in CAD-/CVD-/DM and 1.84 (1.56-2.18) in CAD+/CVD-/non-DM. CVD+ increased the risk of cardiovascular events approximately 4- to 7- fold regardless of CAD+ or DM.
Conclusions:DM increase the risk of cardiovascular disease as high as a history of CAD, while prior CVD alone increased the risk of future cardiovascular disease without additional effects by DM.
Publisher
Research Square Platform LLC
Reference35 articles.
1. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice;Visseren FLJ;Eur Heart J,2021
2. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019, 139(25):e1082-e1143.
3. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association;Kleindorfer DO;Stroke,2021
4. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent C;Lancet,2010
5. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry;Sorbets E;Eur Heart J,2020